Long-term Safety and Efficacy of Subcutaneous Immunoglobulin IgPro20 in CIDP: The PATH Extension Study

被引：0
|
作者：
Mielke, Orell [1 ]
van Schaik, Ivo [2 ]
Bril, Vera [3 ]
van Geloven, Nan [4 ]
Hartung, Hans-Peter [5 ]
Lewis, Richard [6 ]
Sobue, Gen [7 ]
Lawo, John-Philip [1 ]
Praus, Michaela [1 ]
Durn, Billie [1 ]
Cornblath, David [8 ]
Merkies, Ingemar [9 ]
机构：
[1] CSL Behring, King Of Prussia, PA USA
[2] Univ Amsterdam, Amsterdam, Netherlands
[3] Univ Toronto, Toronto, ON, Canada
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
[5] Heinrich Heine Univ, Dusseldorf, Germany
[6] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[7] Nagoya Univ, Nagoya, Aichi, Japan
[8] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[9] Maastricht Univ, Med Ctr, Maastricht, Netherlands
来源：
ANNALS OF NEUROLOGY | 2018年 / 84卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
M275
引用
收藏
页码：S218 / S218
页数：1
相关论文
共 50 条
  • [41] MAINTENANCE TREATMENT FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIPD) WITH SUBCUTANEOUS IMMUNOGLOBULIN IGPRO20: THE MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PATH TRIAL
    Pinter, Lauria G.
    van Schaik, I
    Bril, V
    van Geloven, N.
    Hartung, H.
    Lewis, R.
    Sobue, G.
    Lawo, J.
    Mieke, O.
    Durn, B.
    Cornblath, D.
    Merkies, I
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2019, 24 : S26 - S26
  • [42] Axonal function predicts response to subcutaneous immunoglobulin in CIDP: The PATH study
    Bril, Vera
    Hartung, Hans-Peter
    Sobue, Gen
    Lawo, John-Philip
    Mielke, Orell
    Durn, Billie
    Merkies, Ingemar
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 302 - 302
  • [43] Practical application of subcutaneous immunoglobulin for maintenance treatment in CIDP: The PATH study
    Dimachkie, Mazen
    van Schaik, Ivo
    Bril, Vera
    van Geloven, Nan
    Hartung, Hans-Peter
    Lewis, Richard
    Sobue, Gen
    Lawo, John-Philip
    Mielke, Orell
    Durn, Billie
    Cornblath, David
    Merkies, Ingemar
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 357 - 358
  • [44] Safety and Efficacy Of Subcutaneous Tocilizumab Monotherapy In a Long-Term Extension Study In Japanese Rheumatoid Arthritis Patients.
    Ogata, Atsushi
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S605 - S606
  • [45] Long-Term Safety, Efficacy, and Tolerability of Subcutaneous Human Immunoglobulin 16.5% in Patients with Primary Immunodeficiencies
    Gupta, Sudhir
    Kobayashi, Roger
    Melamed, Isaac
    Rehman, Syed
    Kobayashi, Ai
    Mandujano, jose-Fernando
    Geng, Bob
    Ritchie, Bruce
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB76 - AB76
  • [46] Tolerability of Higher Than Current Infusion Rate and Volume of the 20% Subcutaneous Immunoglobulin IgPro20 in Primary Immunodeficiency: an Open-Label Multicenter Study (HiLo)
    Rojavin, Mikhail A.
    Hofmann, Jutta
    Praus, Michaela
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB114 - AB114
  • [47] Electrophysiological testing in patients with CIDP treated with subcutaneous immunoglobulin: The PATH study
    Bril, Vera
    van Schaik, Ivo
    van Geloven, Nan
    Hartung, Hans-Peter
    Lewis, Richard
    Sobue, Gen
    Lawo, John-Philip
    Mielke, Orell
    Durn, Billie
    Merkies, Ingemar
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 253 - 253
  • [48] Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies
    Kobayashi, Roger H.
    Litzman, Jiri
    Melamed, Isaac
    Mandujano, J. Fernando
    Kobayashi, Ai Lan
    Ritchie, Bruce
    Geng, Bob
    Atkinson, T. Prescott
    Rehman, Syed
    Hoeller, Sonja
    Turpel-Kantor, Eva
    Kreuwel, Huub
    Speer, J. C.
    Gupta, Sudhir
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 210 (02): : 91 - 103
  • [49] Analysis of Relapse by MRC Sum Score in the PATH Study of Subcutaneous Immunoglobulin in CIDP
    Bril, Vera
    Merkies, Ingemar S. J.
    Hartung, Hans-Peter
    Lewis, Richard A.
    Sobue, Gen
    Lawo, John-Philip
    Mielke, Orell
    Durn, Billie L.
    Cornblath, David R.
    van Schaik, Ivo N.
    NEUROLOGY, 2019, 92 (15)
  • [50] Correlation of IgG levels with functional outcomes in the PATH subcutaneous immunoglobulin in CIDP study
    Cornblath, David
    Lewis, Richard
    Bril, Vera
    van Geloven, Nan
    Hartung, Hans-Peter
    Sobue, Gen
    Tortorici, Michael
    Mielke, Orell
    Lawo, John-Philip
    Dum, Billie
    Merkies, Ingemar
    van Schaik, Ivo
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 403 - 404
12345